Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

A-ROSA announces further details of A-ROSA SENA’s sustainability credentials

The first river cruise ship in Europe to generate electricity from exhaust heatRostock, 19 January 2022 – A-ROSA River Cruises has announced further details of the sustainability credentials of its new E-Motion ship A-ROSA SENA, which launches on the northern Rhine in May 2022. The range of technology features on board, which have been developed in partnership with the Concordia Damen shipyard, includes the ability to manage energy consumption in a highly efficient way and keep emissions to a minimum, making her the most climate-friendly river cruise ship on Europe’s rivers. She will be the

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 16 - 19 JANUARY 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 75/2021. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

Invitation to webcast in conjunction with Indutrade’s Year-End Report 2021

Indutrade will publish the Year-End Report 2021 on Wednesday 2 February, at around 7.30 am CET. A webcast will be held on the same day at 9.30 am CET. President and CEO Bo Annvik and CFO Patrik Johnson will present the report, followed by a Q&A session. The presentation will be in English and webcasted live through www.indutrade.com or: https://tv.streamfabriken.com/indutrade-q4-2021For phone access and to ask questions, please call: SE: +46 8 566 427 06UK: +44 3333 00 90 32US: +1 6 467 224 956 The presentation material will be published on our website after the meeting,

SCIENION Partners with Institute for Prevention and Occupational Medicine (IPA) to Develop UROfast, a Rapid Bladder Cancer Diagnostics Platform

The breakthrough diagnostics platform uses a multiplexed lateral flow assay that detects 10 bladder cancer biomarkers from a urine sample in either laboratory or point-of-care settings. Today SCIENION, a BICO company and leading developer of miniaturized multiplex diagnostic tests, announced a partnership with the Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), a German academic research institute of the Ruhr University Bochum, to develop a novel bladder cancer diagnostic platform. The diagnostic multiplexed lateral-flow technology aims

DanCann Pharma A/S: Highly promising analysis results

COPENHAGEN, Denmark, 19 January 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the ambitions to enter the European market with inhouse-produced biomaterial during 2022 has been further supported by the in-house analysis results that the Company has obtained after testing the selected cannabis genetics.DanCann Pharma has now reduced the number of varieties from 95 to nine. The Tetrahydrocannabinol (THC) content of these genetics are in all cases above the general minimum requirements from the market –

Storskogen is contemplating an issue of subsequent bonds under existing framework

Stockholm, January 19, 2022 – Storskogen Group AB (publ) (“Storskogen”) is contemplating an issue of subsequent senior unsecured bonds under an existing framework.Storskogen has mandated DNB Markets, Nordea, SEB and Swedbank as Joint Bookrunners to arrange a series of investor meetings on January 20, 2022, to explore the possibility to issue subsequent bonds of up to SEK 1 billion under the framework of Storskogen’s existing senior unsecured bond loan 2021/2025 (ISIN: SE0017084650) with a total framework of SEK 5 billion, under which an amount of SEK 2 billion is outstanding. The bond issue

AFRY and Tyréns awarded detailed design assignments for the East Link

The assignment assigned to AFRY and Tyréns includes the tender documents for the Gerstaberg – Långsjön railway line in Södertälje. Detailed designing is expected to begin in March 2022 and the entire assignment is expected to be completed in November 2023. The route is part of the East Link Project, a new double-track railway between Stockholm – Linköping, and the first part of Sweden's new main railways for high-speed railways.The Route Gerstaberg – Långsjön in Södertälje is part of the East Link, which at full expansion will be able to be operated by passenger trains with speeds up to 250

Letter from the CEO

As we start 2022, I thought it a good opportunity to review some of the important events of 2021 and discuss our most recent progress.The pandemic has during 2021 continued to play a role but even with the effects of Covid, it has still been a year including many milestones for SciBase. SciBase Strategy, MDR and NMSC SciBase’s strategy is based on gaining traction for our melanoma detection test in key markets and leveraging our core technology Electrical Impedance Spectroscopy (EIS) in additional clinical applications. Each new application uses the same core EIS technology but

Carbiotix starts evaluation project with global laboratory testing company

Carbiotix (publ) ("Carbiotix" or "Company") today announces that the Company has started an evaluation project with a top 5 global laboratory testing company present in over 40 countries and with annual sales exceeding 3 billion Euros. The purpose of the evaluation project will be to assess how Carbiotix LinkGut gut health testing service can be rolled out globally with improvements to cost, reliability and flexibility, while exposing CarbiAXOS and the Company’s Smart Prebiotic concept to leading food & beverage, nutraceutical and pharmaceutical companies.Kristofer Cook, CEO of Carbiotix,

Status update from Playright

Qiiwi Games UK-based subsidiary, Playright Digital Entertainment LTD, is giving a status update regarding on-going projects, game prototypes and 2022 Q1 focus.· 2021 Highlight: Two prototypes out!In December we developed and soft launched two hyper casual game prototypes, Treasure Whacker and Backpacker Hype.  · Treasure Whacker has so far passed through initial marketing tests and is showing promising metrics. The game has also attracted interest from three hyper casual publishers.After the marketing tests we have expanded the design with longer player engagement in mind. Our next

The Pre-Feasibility Study on Dannemora confirms viable possibilities for “green” iron ore production

Grängesberg Exploration Holding AB - GRANGEX - presents the results of the completed Pre-feasibility study (PFS) of the conditions for the recommencement of production in the Dannemora mine. The key objective for the PFS has been to investigate the possibility to develop Dannemora as a carbon-free mine operation. The PFS confirms the possibility of producing a high-grade iron ore concentrate with a much-reduced carbon footprint and that the project should be taken to the final feasibility study stage. The study is a continuation of the Scoping Study presented in May 2021 and shows

Invitation to presentation of Telia Company’s Q4 and full-year 2021 results and strategy progress

Telia Company will publish its financial results for Q4 and the full-year 2021 on Friday January 28, at around 07.00 CET. Presentation and teleconferenceAllison Kirkby, President and Chief Executive Officer, Per Christian Mørland, Chief Financial Officer and Rainer Deutschmann, Chief Operating Officer, will host a teleconference and present the financial results and a strategy progress update at 09.30 CET. The presentation will be held in English and is expected to end around 11.15 CET. Dial in informationIf you would like to ask questions, please use one of the following dial-

Gapwaves receives a new order from a Global Tech Giant

Gapwaves has received a new order of antennas for a high resolution radar from the Global Tech Giant with which a collaboration began in 2020. The order has a value of approximately 10MSEK with expected delivery during the first half of 2022.In August 2020, a collaboration started aiming to develop a antenna for a high resolution 77 GHz radar.  The customer has evaluated the delivered antennas and now chooses to place a new order for additional units as a follow-up. "We are very pleased with this new order and the continued trust from this exciting Tech company, and it’s also the largest

HENT signs major collaboration contract with FREYR for new battery factories in Norway

The Norwegian construction company HENT AS, which is 73% owned by Ratos, has signed a major collaboration contract with FREYR Battery Norway AS. The contract pertains to the construction of new factories to manufacture batteries that will reduce carbon emissions from the rapidly expanding global market for electric mobility.FREYR is planning to build factories to produce up to 43 GWh of battery cell capacity by 2025 and up to 83 GWh in annual capacity by 2028. The first factories will be established in the Mo i Rana Industrial Park in Norway.The first stage in the development is the

KONE publishes January-December 2021 Financial Statement Bulletin on Wednesday, February 2, 2022 at 12:30 p.m. EET and Annual Review 2021 at 12:45 p.m. EET

KONE Corporation, press release, January 19, 2022 at 9.30 a.m. EET Financial Statement Bulletin and Annual Review KONE Corporation will publish its Financial Statement Bulletin for the January 1-December 31, 2021 accounting period on Wednesday, February 2, 2022 at 12:30 p.m. EET. The report will be available on www.kone.com after publishing. The Annual Review 2021, which includes the consolidated financial statements, the parent company financial statements, the Board of Director's report and the Corporate Governance Statement, will be published on the same day at 12:45 p.m. EET. A

Invitation to the presentation of Swedbank’s year-end report 2021

Swedbank’s year-end report 2021 will be published on Wednesday 2 February at 7.00 a.m. CET. Investors and analysts: Conference call on 2 February at 9.00 a.m. CET Jens Henriksson (President and CEO), Anders Karlsson (CFO), Rolf Marquardt (CRO) and Annie Ho (Head of Investor Relations) will present the report. The conference call will be held in English and broadcasted live on www.swedbank.com/ir, where a recording also will be available following the call. To participate in the conference call, dial +46 8 566 42 651 or +44 333 300 0804 using PIN: 42 214 226# five minutes prior to

Invitation to presentation of NOTE´s Year-end Report on 28 January

The Interim Report for the fourth quarter 2021, will be published 28 January at 8:30 a.m. CET. The same day, at 10:00 a.m. CET, NOTE will arrange a teleconference for analysts, media and investors. The report will be presented by NOTE’s CEO and President Johannes Lind-Widestam. The presentation will be held in English. To find more information on how to participate in the conference by phone or online, please right-click on the link here . If you have a problem connecting, try another browser. In connection with the teleconference,

Cint Announces New Executive Committee

Following the completion of the Lucid transaction, which was announced by Cint in October 2021 and completed in December 2021, Cint has now announced a new executive committee. The technical expertise and industry experience of the new executive committee will help to accelerate the integration of Cint and Lucid. The New Executive Committee · Tom Buehlmann, Chief Executive Officer · Joakim Andersson, Chief Financial Officer · Jake Wolff, Chief Revenue Officer · Andy Ellis, Chief Operations Officer · Rick Pittenger, Chief Technology Officer · Marie-Louise Howett, Chief

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 18th January 2022, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 27,104,137 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). On 18 March 2021, the share buy-back programme was increased by DKK 15 million, thereby increasing the maximum aggregate purchase price of the shares to be bought back under the programme to DKK 115 million. The share buy-back

BioStock: Several triggers for Pila Pharma in 2022

There is no doubt that type 2 diabetes has become one of the most common diseases with more than half a billion people affected, according to t International Diabetes Federation. Malmö company Pila Pharma with CEO Dorte X Gram develops a new approach, and, since July 2021, the company’s shares are listed on Nasdaq First North Growth Market. Several milestones have already been reached, and there will be several potential triggers for the stock in 2022.Read the full article at biostock.se:https://www.biostock.se/en/2022/01/several-triggers-for-pila-pharma-in-2022/This is a press release

Cereno Scientific obtains additional patent protection for Phase II drug candidate CS1 in Japan

Cereno Scientific (XSAT: CRNO B) today announced strengthening of intellectual property rights (IPR) for drug candidate CS1 in the major market Japan. The patent is part of the third patent family which now has protection in Russia as well as Japan. It adds to the growing IPR portfolio for CS1 covering almost all global markets.“The expansion of CS1’s patent protection in Japan is an important step in our efforts to protect our innovations and strengthen the commercial positioning of the drug candidate. Japan is one of the largest pharmaceutical markets in the world and it is therefore key

Idogen publishes interim report for 1 January – 31 December 2021

Idogen AB's interim report for January to December 2021 is available on the company's website https://idogen.com/en/investors/financial-reports/   Fourth quarter (October- December 2021) • Other operating income amounted to KSEK 3,335 (1,949) • Operating loss was KSEK -13,552 (-7,449) • Loss for the quarter totalled KSEK -13,529 (-7,897) • Cash flow from operating activities was KSEK -15,074 (-10,428) • Loss per share before dilution was SEK -0.61 (-0.74). Loss per share after dilution was SEK -0.61 (-0.74) • The proposed dividend is SEK 0.00/share (0.00)

Imfinzi improves survival in biliary tract cancer

19 January 2022 07:05 GMT Imfinzi plus chemotherapy reduced risk of death by 20% in 1st-line advanced biliary tract cancer TOPAZ-1 is the first Phase III trial to show improved survivalwith an immunotherapy combination in this setting Combination did not increase discontinuations due to adverse events vs. chemotherapy alone Positive results from the TOPAZ-1 Phase III trial showed AstraZeneca's Imfinzi (durvalumab), in combination with standard-of-care chemotherapy, demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) and

There are no items matching the current filter
There are no more items matching the current filter
Back to top